PRIMARY STUDY
Cognitive Enhancement Therapy in substance misusing schizophrenia: results of an 18-month feasibility trial
Key Findings: In subjects with schizophrenia and either alcohol or cannabis addiction Cognitive Enhancement Therapy (CET) was a feasible and potentially effective treatment for cognitive impairments in these patients.
Type of Study: Clinical Trial
Study Sample Size: 31
Study Result: Positive
Research Location(s): United States
Year of Pub: 2015
Cannabinoids Studied: Cannabinoid (unspecified)
Phytocannabinoid Source: Unspecified
Citation: Eack SM, et al. Cognitive Enhancement Therapy in substance misusing schizophrenia: results of an 18-month feasibility trial. Schizophr Res. 2015; 161:478-83. doi: 10.1016/j.schres.2014.11.017
Authors: Eack SM, Hogarty SS, Greenwald DP, Litschge MY, McKnight SA, Bangalore SS, Pogue-Geile MF, Keshavan MS, Cornelius JR
